Letrazole Femara CAS 112809-51-5

Create: 08/29/2016

Expired Date:	never
Category:	Acrylate intermediates [Chemical]
Message:	Letrazole Femara CAS 112809-51-5 Keywords：Letrozole,FEMARA,LETROZOL,LETRAZOLE,Lelrozol , 112809-51-5, letrozolex Product name: Letrozole CAS: 112809-51-5 MF: C17H11N5 MW: 285.3 Description: Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Skype:Fiona9211 Whatapp:18872220819 Email:Dawn at ycphar dot com






City:	Wuhan Hubei[CN]
Location:

Dec 21 2016	LINCOMYCIN HYDROCHLORIDE	594
Dec 21 2016	Ondansetron hydrochloride	546
Dec 21 2016	Venlafaxine hydrochloride	556
Dec 21 2016	Bupivacaine hydrochloride	560
Dec 21 2016	Butenafine hydrochloride	567
Dec 21 2016	LEVOFLOXACIN HYDROCHLORIDE	546
Dec 21 2016	Levocetirizine dihydrochloride	529
Dec 21 2016	Levamisole Hydrochloride	562
Dec 21 2016	Levobupivacaine hydrochloride	519
Sep 25 2016	High Purity Zopiclone CAS 43200-80-2	601